get a key
steadybase-$ company SBFM
account_id none on file
legal_name Sunshine Biopharma Inc.
ticker SBFM
cik 1402328
domain sunshinebiopharma.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Fort Lauderdale, FL, United States
calls 0 filings 8 executives 1 family 0
why_nownone on file
callsnone on file
filings
and CFO concluded that our disclosure controls and procedures were effective as of June 30, 2026, at reasonable assurance levels.

filing / Aug 13, 2026 / receipt

streamlining operations to reduce expenses. We estimate that our existing cash on hand together with cash we generate from sales will be sufficient to fund our operations for

filing / Aug 13, 2026 / receipt

and CFO concluded that our disclosure controls and procedures were effective as of June 30, 2026, at reasonable assurance levels.

filing / Aug 13, 2026 / receipt

streamlining operations to reduce expenses. We estimate that our existing cash on hand together with cash we generate from sales will be sufficient to fund our operations for

filing / Aug 13, 2026 / receipt

on this evaluation, our management, including our CEO and CFO concluded that our disclosure controls and procedures were effective as

filing / May 13, 2026 / receipt

sales and streamlining operations to reduce expenses. We believe these measures could bring us to breakeven and make us less dependent

filing / May 13, 2026 / receipt

on this evaluation, our management, including our CEO and CFO concluded that our disclosure controls and procedures were effective as

filing / May 13, 2026 / receipt

sales and streamlining operations to reduce expenses. We believe these measures could bring us to breakeven and make us less dependent

filing / May 13, 2026 / receipt

executives
Michel Roy Chief Commercial Officer - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2025-01-15 Chief Commercial Officer, appointed sec_8k
2015-02-24 Chief Operating Officer, departed sec_8k
mcp_package_hint
steadybase-$